Allurion Technologies (NYSE:ALUR – Get Free Report) is anticipated to release its earnings data before the market opens on Wednesday, March 26th. Analysts expect Allurion Technologies to post earnings of ($4.75) per share and revenue of $5.60 million for the quarter. Parties that wish to register for the company’s conference call can do so using this link.
Allurion Technologies Trading Up 57.7 %
ALUR opened at $3.60 on Monday. The firm has a market capitalization of $17.24 million, a PE ratio of -0.30 and a beta of -0.59. Allurion Technologies has a twelve month low of $2.15 and a twelve month high of $98.75. The firm’s 50-day moving average price is $4.00 and its 200 day moving average price is $10.10.
Analyst Ratings Changes
A number of equities research analysts have recently issued reports on the company. Chardan Capital restated a “neutral” rating and issued a $2.50 price target on shares of Allurion Technologies in a research report on Friday. Roth Mkm reissued a “buy” rating and set a $16.00 price objective on shares of Allurion Technologies in a research note on Friday.
About Allurion Technologies
Allurion Technologies Inc focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite.
See Also
- Five stocks we like better than Allurion Technologies
- Following Congress Stock Trades
- AbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market
- What is the MACD Indicator and How to Use it in Your Trading
- 3 ETFs to Ride the VIX Surge During Market Volatility
- What is a Dividend King?
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
Receive News & Ratings for Allurion Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allurion Technologies and related companies with MarketBeat.com's FREE daily email newsletter.